Episode Summary
Executive Summary: Bain Capital leaders David Humphrey and Devin O’Reilly explain how Zealous fits Bain’s market-first, partnership-oriented investing style: identify large, underpenetrated problems, back advantaged businesses, and actively help scale them. They describe combining Zealous and Red Card to digitize healthcare pricing, payments, and communications, the deal process, capital structure, growth through acquisitions, management continuity, and possible exits.
Main Topics: Bain Capital’s investing philosophy (Priority: 5/5): Bain’s consulting roots emphasize understanding markets, competition, and structural advantage before underwriting a company. The firm seeks businesses solving important customer problems with moat-like positions and meaningful growth inflection points. Why healthcare payments was attractive (Priority: 5/5): The team identified healthcare payments as a fragmented, inefficient, and under-digitized system with major friction for patients, payers, and providers—an opportunity to remove cost and improve experience. Combining Zealous and Red Card (Priority: 5/5): Bain partnered with Parthenon to merge two complementary businesses into a vertically integrated platform that prices claims, facilitates payments, and communicates benefits and payment information. Deal sourcing, diligence, and auction process (Priority: 4/5): The opportunity emerged through boardroom observations, internal expertise, advisor introductions, and a competitive but relationship-driven process with Parthenon that Bain won by leaning in on value and partnership. Ownership strategy and operating plan (Priority: 4/5): After closing, Bain focused on integration, preserving entrepreneurial culture, expanding sales effectiveness, supporting innovation, and adding talent while maintaining flexibility through modest leverage. Growth, acquisitions, and leadership (Priority: 4/5): Since acquisition, Zealous has grown rapidly, completed tuck-ins including Sapphire and Payer Compass, and added experienced leaders like Amanda Eisel and Brian Gladden to support the next phase. Exit optionality and lessons learned (Priority: 3/5): The sponsors see multiple exit paths—IPO, recap, or strategic sale—but are in no rush. Key lessons include valuing high-quality growth businesses, prioritizing people, and recognizing mission-driven companies.
Key Arguments: Bain’s edge is spending deeply on market structure and competitive dynamics before focusing on financing terms. Healthcare payments are a huge, still-inefficient market with a large paper-check tail and strong digitization potential. Zealous and Red Card were complementary assets whose combination created a more complete platform for pricing, paying, and communicating claims. The business was already scaled and profitable, so the investment was a growth-at-scale deal rather than a venture bet. Bain paid a full price because the company’s moat, market size, and upside outweighed the risks. Preserving entrepreneurial culture and existing talent was central to post-close value creation. Using moderate leverage preserved flexibility for future M&A and product investment. The company has multiple plausible exits because of its growth, scale, profitability, and strategic relevance. The management team and legacy investors were important to aligning incentives and execution. The deal demonstrates that healthcare technology can improve patient experience while also lowering system costs.
Data Points: Bain Capital AUM: $180 billion - Firm-wide assets under management mentioned in the introduction Private equity share of AUM: About half - Roughly half of Bain Capital’s assets are in private equity Founded/spun out from Bain & Company: 1984 - Bain Capital’s origin story described by the speakers Zealous / transaction timing: 2019 - Bain joined Parthenon in the Zealous transaction in 2019 Earlier Bain healthcare/payments investment: 2016-2017 - Waystar-related investment and formation referenced as an antecedent to Zealous Healthcare share of economy: One-sixth - Used to frame the size of the healthcare market Annual healthcare payments: About $2 trillion - Total healthcare payments flowing through the system annually Paper checks in healthcare: $500 billion per year - Estimated paper-check volume in healthcare at the time of investment Revenue at purchase: About $500 million - Zealous was already a scale business when acquired Growth at purchase: Well over 20% - Revenue growth rate at the time of acquisition Profitability at purchase: Very profitable - Zealous was described as a profitable growth business Customer penetration: 90 of the top 100 payers - Current payer relationships cited for Zealous Provider base: Thousands of providers - Current network footprint mentioned Auction price increase: 12% to 15% - Increase from first-round bid to final bid Acquisition price: $5.7 billion - Final price Bain paid to win the deal Initial leverage: 4x to 5x - Debt used at closing; intentionally conservative for a growth deal Current revenue: Over $1 billion this year - Current scale of Zealous after ownership period Organic revenue growth: More than 20% annually - Reported growth trajectory during ownership Recent acquisitions: 2 - Sapphire and Payer Compass were completed under Bain ownership Target future scale: $2 billion then $5 billion revenue - Long-term ambition discussed for Zealous Bain technology growth dollars: Up to one-third in some years - Bain noted that tech PE dollars increasingly go to growth investments
Pivotal Quotes: "We are looking for situations where a business is of fundamentally really high quality... and it's a business at some inflection point." — David Humphrey: Explaining Bain Capital’s investment philosophy and what it seeks in deals "Boy, there must be a better way to affect healthcare payments." — David Humphrey: Describing the moment that sparked Bain’s interest in the healthcare payments opportunity "Pay for care with care." — Devin O’Reilly: Zealous’s mission orientation and the consumer/patient-focused rationale for the business
Implications: The episode shows how private equity can create value in healthcare by consolidating adjacent assets, preserving entrepreneurial talent, and funding digital infrastructure. It also highlights ongoing market demand for scalable, mission-driven healthcare IT platforms.
About Private Equity Deals
Allocator and asset management expert, Ted Seides, conducts in-depth interviews with interviews with top institutional money managers across private markets. Guests include principals and senior leaders from private equity, private credit, real assets, and other alternatives. We dive deep into individual deals to learn about deal dynamics, companies, and ownership that make private equity a force in institutional portfolios and the global economy. Learn more and join our community at capitalallocators.com.